Patents by Inventor Tom Lavrijsen

Tom Lavrijsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Implant
    Patent number: 11452624
    Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: September 27, 2022
    Assignee: Xeltis AG
    Inventors: Tom Lavrijsen, Anandkumar Nandakumar, Martijn Antonius Johannes Cox, Franciscus Petrus Thomas Baaijens, Carolina Victoria Catharina Bouten, Anton Bosman, Tristan Mes, Patricia Yvonne Wilhelmina Dankers
  • In situ tissue engineering
    Patent number: 10933163
    Abstract: The present disclosure relates to in situ tissue engineering, more specifically in situ vascular tissue engineering with the aim of providing a tissue structure which can be used e.g. as a substitute blood vessel or as a blood vessel functioning as cannulation site in hemodialysis. In particular, the disclosure involves tissue structure formation around a subcutaneously implanted synthetic rod. In addition, the disclosure involves a method for producing said synthetic rod.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: March 2, 2021
    Assignees: Academisch Ziekenhuis Leiden, Xeltis B.V., Universiteit Maastricht
    Inventors: Joris Ivo Rotmans, Tonia Caroline Rothuizen, Lorenzo Moroni, Clemens Antoni Van Blitterswijk, Febriyani Fiain Rochel Damanik, Tom Lavrijsen, Martijn Antonius Johannes Cox, Antonius Johannes Rabelink
  • Implant
    Publication number: 20200276034
    Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.
    Type: Application
    Filed: May 18, 2020
    Publication date: September 3, 2020
    Inventors: Tom Lavrijsen, Anandkumar Nandakumar, Martijn Antonius Johannes Cox, Franciscus Petrus Thomas Baaijens, Carolina Victoria Catharina Bouten, Anton Bosman, Tristan Mes, Patricia Yvonne Wilhelmina Dankers
  • Implant
    Patent number: 10687966
    Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: June 23, 2020
    Assignees: Xeltis AG, Technische Universiteit Eindhoven
    Inventors: Tom Lavrijsen, Anandkumar Nandakumar, Martijn Antonius Johannes Cox, Franciscus Petrus Thomas Baaijens, Carolina Victoria Catharina Bouten, Anton Bosman, Tristan Mes, Patricia Yvonne Wilhelmina Dankers
  • IN SITU TISSUE ENGINEERING
    Publication number: 20190167845
    Abstract: The present disclosure relates to in situ tissue engineering, more specifically in situ vascular tissue engineering with the aim of providing a tissue structure which can be used e.g. as a substitute blood vessel or as a blood vessel functioning as cannulation site in hemodialysis. In particular, the disclosure involves tissue structure formation around a subcutaneously implanted synthetic rod. In addition, the disclosure involves a method for producing said synthetic rod.
    Type: Application
    Filed: January 31, 2019
    Publication date: June 6, 2019
    Applicants: Academisch Ziekenhuis Leiden, Xeltis B.V., Universiteit Maastricht
    Inventors: Joris Ivo Rotmans, Tonia Caroline Rothuizen, Lorenzo Moroni, Clemens Antoni Van Blitterswijk, Febriyani Fiain Rochel Damanik, Tom Lavrijsen, Martijn Antonius Johannes Cox, Antonius Johannes Rabelink
  • In situ tissue engineering
    Patent number: 10232081
    Abstract: The present disclosure relates to in situ tissue engineering, more specifically in situ vascular tissue engineering with the aim of providing a tissue structure which can be used e.g. as a substitute blood vessel or as a blood vessel functioning as cannulation site in hemodialysis. In particular, the disclosure involves tissue structure formation around a subcutaneously implanted synthetic rod. In addition, the disclosure involves a method for producing said synthetic rod.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: March 19, 2019
    Assignees: Academisch Ziekenhuis Leiden, Xeltis B.V., Universiteit Maastricht
    Inventors: Joris Ivo Rotmans, Tonia Caroline Rothuizen, Lorenzo Moroni, Clemens Antoni Van Blitterswijk, Febriyani Fiain Rochel Damanik, Tom Lavrijsen, Martijn Antonius Johannes Cox, Antonius Johannes Rabelink
  • Implant
    Publication number: 20180153717
    Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.
    Type: Application
    Filed: December 14, 2017
    Publication date: June 7, 2018
    Inventors: Tom Lavrijsen, Anandkumar Nandakumar, Martijn Antonius Johannes Cox, Franciscus Petrus Thomas Baaijens, Carolina Victoria Catharina Bouten, Anton Bosman, Tristan Mes, Patricia Yvonne Wilhelmina Dankers
  • Implant
    Patent number: 9877852
    Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.
    Type: Grant
    Filed: July 5, 2013
    Date of Patent: January 30, 2018
    Assignees: Xeltis, BV, Technische Universiteit Eindhoven
    Inventors: Tom Lavrijsen, Anandkumar Nandakumar, Martijn Antonius Johannes Cox, Franciscus Petrus Thomas Baaijens, Anton Bosman, Carolina Victoria Catharina Bouten, Tristan Mes, Patricia Yvonne Wilhelmina Dankers, Serge Hendrikus Mathijs Söntjens, Henricus Marie Janssen
  • IN SITU TISSUE ENGINEERING
    Publication number: 20170128623
    Abstract: The present disclosure relates to in situ tissue engineering, more specifically in situ vascular tissue engineering with the aim of providing a tissue structure which can be used e.g. as a substitute blood vessel or as a blood vessel functioning as cannulation site in hemodialysis. In particular, the disclosure involves tissue structure formation around a subcutaneously implanted synthetic rod. In addition, the disclosure involves a method for producing said synthetic rod.
    Type: Application
    Filed: June 16, 2015
    Publication date: May 11, 2017
    Inventors: Joris Ivo Rotmans, Tonia Caroline Rothuizen, Lorenzo Moroni, Clemens Antoni Van Blitterswijk, Febriyani Fiain Rochel Damanik, Tom Lavrijsen, Martijn Antonius Johannes Cox, Antonius Johannes Rabelink
  • IMPLANT
    Publication number: 20150173921
    Abstract: The disclosure lies in the field of regenerative medicine and relates to an implant having a matrix material, and a method for manufacturing an implant having matrix material. The disclosure further relates to a crimped implant.
    Type: Application
    Filed: July 5, 2013
    Publication date: June 25, 2015
    Inventors: Tom Lavrijsen, Anandkumar Nandakumar, Martijn Antonius Johannes Cox